Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

4 CLINICS GROUP SPRL

UEI: LRLBQ37CNFQ8

4 CLINICS GROUP SPRL is a federal contractor, registered under UEI LRLBQ37CNFQ8. It has been awarded $50,000 across 1 federal contract. Primary work spans In-Vitro Diagnostic Substance Manufacturing. Top awarding agencies include Department Of Health And Human Services (hhs).

Contact Information

Registration and classification details

Registration

UEI Code

LRLBQ37CNFQ8

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Health And Human Services (hhs)$50.0K100%

Awards by NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing$50.0K100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in 4 CLINICS GROUP SPRL's top NAICS codes and agencies

CONTROL LOOP SET

Solicitation # SPE2DS-26-T-291B

The CONTROL LOOP SET is a microbiology product containing Streptococcus pyogenes ATCC 19615 culture loops, provided in packages of five units per PG, and designed for use in controlled laboratory settings. It requires strict refrigeration storage between 2 to 8 degrees Celsius and must not be frozen. The item has a non-extendable shelf life of 15 months, with no more than two months elapsed between the date of manufacture and delivery to the government. Labeling must include the date of manufacture, expiration or retest date, and the contract or lot number, in compliance with the latest Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards, ensuring protection against damage during transit, and must be suitable for safe delivery by common carriers at the lowest cost to the specified point of delivery. All packaging and marking must adhere to the latest MMS1C guidelines. The product is subject to DLA packaging requirements and must not carry government identification if rejected. This item falls under NSN 6550-01-691-8597 with a purchase quantity of one PG and a delivery expectation of 20 days after award. The solicitation is issued under contract SPE2DS-26-T-291B with a response deadline of August 5, 2026, and is managed by the Department of Defense’s Medical Supply Chain for the Office of Surgical and Medical Support. Technical and quality requirements referenced under R and I numbers are governed by the DLA Master List of Technical and Quality Requirements, and the contract incorporates provisions for covered defense information and federal procurement protocols.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC

Solicitation # 36C26026Q0905

The Seattle VA Medical Center is seeking information on the procurement of rapid syndromic molecular testing reagents through a sources sought notice issued under solicitation number 36C26026Q0905. The requirement is aimed at acquiring reagents used for fast and accurate diagnostic testing of infectious syndromes to support clinical care at the facility, with performance located in Seattle, Washington. The request is hosted by the 260-NETWORK Contract Office 20 under the Department of Veterans Affairs, and responses are due by August 6, 2027. No set-aside provisions are being applied, and the NAICS code 325413 indicates this relates to pharmaceutical and medicine manufacturing. The primary point of contact for inquiries is Hector D. Baltazar, with James Harris listed as a secondary contact. All details regarding technical specifications, volumes, and performance requirements are contained in the accompanying attachments, with interested parties encouraged to review them before submitting responses.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

in about 1 year

Notice of Intent / Sole Source Solid Waste

Solicitation # 75H71026Q00223

The Navajo Area Indian Health Service, Shiprock Service Unit, intends to award a sole-source, firm-fixed-price contract to Navajo Sanitation for solid waste collection services at the Dzilth-Na-O-Dith-Hle Health Center in Bloomfield, New Mexico, with performance beginning September 1, 2026, and ending August 31, 2027. The procurement is justified under unusual and compelling urgency due to the contractor’s unique, uninterrupted history of providing essential waste management services at the facility, ensuring continuity of operations critical to patient care. The North American Industry Classification System code is 562111, with a small business size standard of $47 million in annual revenue. No competitive solicitation will be issued unless a respondent submits clear and convincing evidence that competition would benefit the government. Responses must be submitted in writing as a capability statement by August 17, 2026, at 10:00 a.m. MST, and must not include proprietary, classified, confidential, or sensitive information. The government is not obligated to respond to or acknowledge submissions, and failure to receive affirmative responses will result in contract award without further notice. All information provided may be used in future solicitations if competition is pursued, and any resulting solicitation will be publicly announced on SAM.gov. The point of contact for inquiries is Ken Parrish, Purchasing Agent, reachable at ken.parrish@ihs.gov.

Department Of Health And Human Services

POSTED

DEADLINE

TEST KIT, MENINGITIS AN

Solicitation # SPE2DS-26-T-285X

The contract pertains to the procurement of a meningitis antigen detection test kit designed for the rapid qualitative detection of bacterial antigens in cerebrospinal fluid and other body fluids or blood culture supernatants. The kit employs latex agglutination technology to identify antigens from Streptococcus group B, Haemophilus influenzae type B, Streptococcus pneumoniae, Neisseria meningitidis groups A, B, C, Y, and W135, and Escherichia coli K1. Each kit contains sufficient reagents and supplies for 30 tests and must be stored refrigerated between 2 and 8 degrees Celsius with no freezing permitted. The kit is classified as a TYPE I (CODE G) medical item with a non-extendable shelf life of 9 months, and delivery to the government must occur within 1 month of manufacture. All packaging and labeling must comply with Medical Marking Standard No. 1, including clear indications of manufacture date, expiration date, contract number, and lot number. The kit is issued as a single unit containing 30 tests under NSN 6550-01-692-4637, with delivery required within 20 days of award. The procurement follows Defense Logistics Agency packaging and quality requirements, and technical specifications referenced in the DLA Master List of Technical and Quality Requirements are fully applicable. The solicitation number is SPE2DS-26-T285X, with a response deadline of August 4, 2026, and the contracting agency is the Department of Defense under the Medical Supply Chain MD Surg FSF.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

ASSAY KIT, ERYTHROCY

Solicitation # SPE2DS-26-T-287G

The assay kit is designed for the quantitative measurement of erythrocyte cholinesterase in whole blood to monitor exposure to pesticides or nerve agents. It includes all necessary components for 96 tests: assay buffer, premeasured single-use reagents, capillary tubes, wipes, distilled water, transfer pipettes, a 9-volt battery, and a package insert. The device is regulated by the FDA and requires confirmation via EBS referral by the contracting official, including bidder and manufacturer details. It must have a non-extendable shelf life of 12 months and be packaged in commercial-grade sealed unit containers that protect against damage, with exterior shipping containers suitable for safe, cost-effective transport to the delivery point. Packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and follow MIL-STD-2073-1E for preparation. The item is identified by NSN 6550-01-524-4560 and part number MODEL 460 from EQM RESEARCH INC, with a unit of issue of each. Delivery is required FOB destination within 20 days, with no variance allowed in quantity. The solicitation was issued under SPE2DS-26-T-287G, with responses due by August 4, 2026, and performance directed to Fort Bliss, Texas.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

KIT, PERFORMANCE QUALIF

Solicitation # SPE2DS-26-T-284S

This contract specifies the procurement of a Performance Qualification Kit for Electrochemiluminescence (ECL) use with the MSD PR2 Model 1800, comprising ten plates and associated reagents. The item is classified as a Type I (Code H) product with a non-extendable shelf life of twelve months and must be stored at room temperature. It is regulated by the FDA, and bidders are required to clearly state the source and part number being supplied, with the manufacturer identified as Meso Scale Diagnostics LLC under part number ECL-PR2-PQ. The National Stock Number is 6550-01-694-0651, and the unit of issue is a single kit. The contract mandates strict adherence to commercial packaging standards as outlined in MEDICAL MARKING STANDARD NO. 1, which supersedes MIL-STD-129, and all packaging must ensure protection against damage during transit. The material must be marked per the specified standard and palletized in compliance with DLA packaging requirements. Delivery is required within five days of contract award, with FOB destination and zero variance allowed on quantity. The inspection and acceptance points are both at the destination, and the shipment must be sent to the specified APO address with an alternate freight shipping address in Yokota AB, Japan. The contract references DLA technical and quality requirements incorporated by reference, including RS011, RP001, and RQ011, and applies all medical acquisition packaging rules. The solicitation number is SPE2DS-26-T-284S, with a response deadline of August 4, 2026, and the required delivery date is July 31, 2026. The contracting office is under the Department of Defense, Medical Supply Chain MD Surg FSF, with Tiffany Parker as the primary point of contact. All packaging, marking, and shipping must comply with MIL-STD-2073-1E and DLA procedural notes for transportation and delivery.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, CHLAMYDIA TRA

Solicitation # SPE2DS-26-T-281C

This contract is for the procurement of a qualitative direct immunofluorescence test kit designed for the detection of Chlamydia trachomatis in human urogenital and ocular specimens, as well as for confirming Chlamydiae in cell culture. The kit includes two positive control slides, mounting fluid, and the Chlamydia test reagent, ensuring reliable and standardized diagnostic capability. The item is identified by NSN/Part Number 6550-01-725-3600, with a single kit ordered under Purchase Request 7017651737. Delivery is expected within 20 days after order. The solicitation, numbered SPE2DS-26-T-281C, was posted on July 28, 2026, with responses due by August 3, 2026, under a federal procurement process managed by the Department of Defense through the Medical Supply Chain MD Surg FSF office. The place of performance is listed as APO with ZIP code 09094-3219, indicating military or overseas delivery. The primary point of contact is Mary-Kathryn Donahue, reachable via email and phone for inquiries. The NAICS code 325413 classifies this as a pharmaceutical and medicine manufacturing activity, affirming the technical and regulatory standards applicable to the test kit's production and distribution.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, BACTERIA DETE

Solicitation # SPE2DS-26-T-278C

The test kit is a single-use, self-contained system designed for the rapid detection of coliforms, E. coli, and hydrogen sulfide-producing Enterobacteriaceae such as Salmonella and Citrobacter in food, beverages, and water samples. It incorporates a specialized gelling agent that enables both presence/absence testing and quantification of colony forming units with a sensitivity of 1 CFU per 100 mL in water and 1 CFU per 3 mL in juice, delivering results within 28 hours. The unit of issue is PG, with 25 kits per package, and it is identified by NSN 6550-01-723-3649. The product must comply with mandatory technical and quality requirements referenced in the DLA Master List and adhere to medical packaging standards, specifically Medical Marking Standard No. 1, which replaces MIL-STD-129. Each unit must be sealed in a protective container and shipped in commercial exterior packaging suitable for safe delivery via common carrier at the lowest cost to the specified delivery point at Fort Bragg, NC. The item has a non-extendable shelf life of six months, with no more than one month elapsed between manufacture and government delivery. Storage and shipping must occur at 15 to 25 degrees Celsius, and all labels must include the manufacture date, expiration date, retest date, contract number, and lot number, formatted per the latest MMS1C guidelines. Bidders are required to specify the source and part number being offered, and the solicitation under contract number SPE2DS-26-T-278C closes on August 3, 2026, with delivery expected within 20 days after award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL LOOP SET

Solicitation # SPE2DS-26-T-282G

The CONTROL LOOP SET is a microbiological control culture item specifically designed for Streptococcus pyogenes ATCC 19615, intended for use in laboratory quality control procedures. It requires refrigerated storage between 2 to 8 degrees Celsius and must not be frozen. Each package contains five units, designated as one PG (package), and must be packaged and marked in strict compliance with Medical Marking Standard No. 1, replacing all references to MIL-STD-129. The item has a non-extendable shelf life of 15 months, with no more than two months allowed to have passed from the date of manufacture to the date of delivery to the government. All labels must clearly display the date of manufacture, expiration or retest date, and the contract or lot number, following the latest revision of MMS1C. This item is subject to DLA packaging and labeling requirements, and all supplies must be properly sealed and packed in commercial-grade containers suitable for safe transport by common carriers at the lowest cost to the designated delivery point, which is APO 09094-3219. The procurement is governed by technical and quality requirements identified in the DLA Master List and is classified as a TYPE I (CODE J) item under shelf-life regulation RS012. The National Stock Number is 6550-01-691-8597, with a single package ordered under purchase request 7017651773, and delivery is required within five days of award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-26-T-280F

The contract is for the procurement of 5 cases of Abbott BinaxNOW COVID-19 Antigen Self Tests, each case containing 12 kits with two tests per kit, for at-home, over-the-counter use. Each test kit must be stored between 2°C and 30°C and must have a shelf life of exactly 12 months with no extensions permitted, and no more than one month may have passed from the date of manufacture to the date of delivery to the government. All units must be packaged commercially in sealed containers that protect against damage, with exterior shipping containers suitable for safe, cost-effective delivery via common carriers. Labeling must comply with Medical Marking Standard No. 1, including the date of manufacture, expiration date, contract number, and lot number, and all government identification must be removed from non-accepted supplies. Technical and quality requirements referenced in the DLA Master List of Technical and Quality Requirements are incorporated by inclusion, and the items are subject to the DLA packaging standards and marking specifications. The contract is tied to NSN 6550-01-716-1573, with a delivery requirement within 20 days after order, and falls under the solicitation SPE2DS-26-T-280F issued by the Department of Defense, with primary point of contact at DLA Troop Support.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Illumina Respiratory Virus Enrichment Kit, MiSeq Reagent Nano Kit, and PhiX Control

Solicitation # N6311626Q0555

The Naval Health Research Center in San Diego, California, intends to award a sole-source contract to ILLUMINA, INC. under the statutory authority of 10 U.S.C. 3204(a)(1), which permits procurement from only one responsible source. The contract is for the supply of specific laboratory reagents and kits including the Illumina Respiratory Virus Enrichment Kit Set A with 96 indexes and 96 samples, the MiSeq Reagent Nano Kit v2 (300-cycles), and the PhiX Control v3. These materials are essential for respiratory virus research and genomic sequencing activities conducted at the center. Although this is a notice of intent and not a formal request for proposals, the government will consider any responses from responsible sources that submit timely and complete information. All potential responders must be registered in SAM.gov and have completed all required FAR and DFARS representations and certifications. Deliveries are scheduled to occur between September 2, 2026, and March 2, 2027. Submissions must reference solicitation number N6311626Q0555 and include the company name, full address, CAGE code, and detailed point of contact information consisting of name, phone number, and email address. The primary point of contact for this procurement is David L. Hill, and the place of performance is in San Diego, California. Responses are due by August 5, 2026, and all submissions must adhere to the specified format and documentation requirements to be considered.

Naval Health Research Center

POSTED

DEADLINE

GLA VA - 10X Genomics Visium HD kit - Genomics Reagents

Solicitation # 36C26226Q1264

The Department of Veterans Affairs is seeking a qualified small business vendor to supply a 10X Genomics Visium HD kit for spatial single-cell RNA sequencing in support of Dr. Philip Scumpia’s research. The solicitation, identified as 36C26226Q1264, is a small business set-aside under NAICS code 325413 for genomics reagents, with a response deadline of August 18, 2026. The required products include the Visium HD Mouse Transcriptome kit with 8 reactions and the Visium CytAssist Alignment Aid Kit, both of which must be U.S.-made or from designated country end products under federal trade agreements. Proposals must include a formal quote, a letter of authorization from the manufacturer, and full vendor details including business size, socioeconomic classification, UEI number, and confirmation of authorized distributor status if applicable. The contract is being managed by the VA office in Long Beach, California, with performance to occur in Los Angeles, and all inquiries should be directed to Sabrina Schofield.

262F Nco 22 Nonary VA Care (00262F)

POSTED

DEADLINE

TEST KIT, E COLI DETECT

Solicitation # SPE2DS-26-T-276M

The contract is for the procurement of Colilert-18 test kits designed to detect both total coliforms and Escherichia coli in water or fecal coliforms in wastewater, with results available within 18 hours. The kits must be stored between 2 and 25 degrees Celsius and protected from light. The product is regulated by the FDA, requiring a referral to a product specialist for confirmation prior to award. The items must be supplied with an identified source and part number, specifically IDEXX DISTRIBUTION INC P/N 98-00876-00 or IDEXX LABORATORIES INC P/N 98-08876-00, and must comply with all applicable technical and quality requirements referenced in the DLA Master List. A shelf life of 15 months, non-extendable, is mandated under RS001 for TYPE I (CODE J) items. Packaging and labeling must adhere to the Medical Marking Standard No. 1, superseding MIL-STD-129, with each unit sealed in a protective container and packed in commercial shipping containers suitable for safe transit at the lowest possible rate. The unit of issue is PG, with a total quantity of 3 packs required. Delivery is FOB destination within 20 days, with zero variance allowed in quantity. The delivery address is Peterson Air Force Base, Colorado, and shipping must be conducted via traceable means, explicitly excluding parcel post. All packaging and marking must comply with the latest version of the DLA Medical Marking Standard, and the contract is subject to Defense Federal Acquisition Regulation Supplement requirements including potential handling of covered defense information. The solicitation number is SPE2DS-26-T-276M with a response deadline of August 3, 2026, and the original required delivery date is July 29, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Combined Synopsis Solicitation- Acquire 32-sample

Solicitation # 75N98026Q00881

The National Institutes of Health, through the Department of Health and Human Services, is soliciting proposals under a non-competitive combined synopsis and solicitation for the acquisition of a 32-sample product, identified by solicitation number 75N98026Q00881. This procurement is conducted under FAR Part 12.603 as a streamlined process for commercial items and falls below the simplified acquisition threshold, utilizing statutory authority under 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii) to justify the absence of full and open competition. The solicitation is issued as a Notice of Intent and serves as the only formal request for proposals, with no additional written solicitation to follow. Proposals must be submitted by the deadline of August 3, 2026, at 6:00 p.m. Eastern Time, following the posting date of July 27, 2026. The contracting activity is managed by the Office of Acquisition and Logistics Operations in Bethesda, Maryland, with the NAICS code 325413 indicating the product relates to pharmaceutical and medicine manufacturing. The primary point of contact for inquiries is Cassie M. Runner, reachable via email at cassie.runner@nih.gov or phone at 301-480-8827. The place of performance has not been specified, but the contract award will be directed toward a commercial supplier capable of meeting requirements without competitive bidding, in alignment with the streamlined procedures and statutory exceptions under federal acquisition regulations. All responses must comply with the terms outlined in the combined synopsis, and no further documentation will be issued beyond this notice.

National Institutes Of Health Olao

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-26-T-269U

The contract seeks the procurement of coronavirus test kits under the NSN 6550-01-716-1573, with a specific line item for the Abbott BinaxNOW COVID-19 Antigen Self Test, OTC, At Home Use, totaling three units. The solicitation is issued under SPE2DS-26-T-269U by the Defense Logistics Agency, a Department of Defense entity, with a posted date of July 26, 2026, and a response deadline of August 3, 2026. The acquisition is governed by the NAICS code 325413 for medical and surgical manufacturing. Delivery is required to the USS OKANE DDG 77 with an FOB Destination term and must be completed within 20 days after order placement. The packaging and labeling of the test kits must adhere to DLA’s Medical Marking Standard No. 1, MIL-STD-2073-1E for packaging, and MIL-STD-129 for marking where applicable, with strict environmental controls requiring storage between 2–30°C. The test kits must have a 12-month non-extendable shelf life, with no more than one month allowed between manufacture and delivery. Hazardous materials associated with the kits require labeling under 29 CFR 1910.1200 and submission of Safety Data Sheets prior to award. All shipments must include ocean bill of lading data if transported by sea and must be invoiced through WAWF with specific DoDAAC routing fields, including Pay Official, Issue By, and Admin DoDAAC. Payment is managed via WAWF, with no mention of alternative systems. The contract includes numerous FAR and DFARS clauses related to labor compliance, trafficking prevention, employment verification, sustainable products, hazardous material handling, cybersecurity assessments, export control, and prohibitions on certain Chinese military company products. Offerors must provide UEI and CAGE codes for compliance with defense telecommunications and joint venture disclosures. The contracting officer’s point of contact is Anh Lam with a direct phone number and email. No evaluation factors, contract type, or total value are specified in the available data.

Defense Logistics Agency

POSTED

DEADLINE

TEST KIT, HUMAN IMMUNOD

Solicitation # SPE2DS-26-T-269L

The Defense Logistics Agency is soliciting a contract for the procurement of 7 units of the Human Immunodeficiency Virus Test Kit, identified by NSN 6550-01-692-1809, under solicitation SPE2DS-26-T-269L, with a response deadline of August 3, 2026. The contract is issued under NAICS code 325413 for medical and pharmaceutical manufacturing and is intended for delivery to Kaiserslautern, Germany, with an FOB destination term requiring delivery within 83 days after receipt of order, no later than July 24, 2026. Compliance with stringent packaging and labeling standards is mandatory, including adherence to the Medical Marking Standard No. 1 (MMS No. 1), which supersedes MIL-STD-129 for all medical items; packaging must meet MIL-STD-2073-1E requirements, maintain storage temperatures between 2–30°C, and be palletized according to DLA’s RP001 guidelines. Bar-coding, shelf-life markings including manufacture and expiration dates, contract number, and lot number must be applied as specified under MMS1C. Inspection and acceptance occur at the destination, governed by FAR 52.246-2. Performance is subject to multiple FAR and DFARS clauses addressing employment practices, trafficking prevention, electronic payments via WAWF, cybersecurity safeguards including NIST SP 800-171 assessments, hazardous material handling, export controls, and prohibitions on sourcing from communist Chinese military companies. The contract requires electronic submission through DIBBS and mandates payment requests via Wide Area WorkFlow using the Invoice and Receiving Report format for fixed-price items. Offerors must possess a valid UEI and CAGE code and may be required to self-certify as a small business or within socioeconomic categories such as WOSB, SDVOSB, or HUBZone, with no evaluation factors or award criteria disclosed. No pricing details in a structured Section B format are available, so contract value cannot be confirmed. Hazard communication compliance under 29 CFR 1910.1200 and pre-award submission of hazard label plans are required, and any provision of covered defense telecommunications equipment triggers mandatory disclosures. All documentation must align with the DLA Master Solicitation for Automated Simplified Acquisitions, Revision 105.

Defense Logistics Agency

POSTED

DEADLINE

BACTERIOLOGICAL SPECIM

Solicitation # SPE2DS-26-T-271J

The contract solicitation SPE2DS-26-T-271J, issued by the Defense Logistics Agency under the Department of Defense, seeks the procurement of two units of a bacteriological specimen collection and transportation system with transport media, identified by NSN 6550-01-474-0651. Deliveries are required to be made within 20 days after award to the U.S. Navy vessel USS DECATUR DDG 73 at FPO AP 96663-1290, with FOB Destination terms applying. The solicitation was posted on July 26, 2026, and responses are due by August 3, 2026, to be submitted exclusively through the DLA Internet Bid Board System using Standard Form 18. While no pricing information is populated in the current solicitation, historical procurement data indicates prior unit costs ranging from approximately $44 to $54 per unit. Packaging must comply with ASTM D3951 for non-hazardous materials and TQ Requirement IP025 for hazardous substances, with labeling adhering to MIL-STD-129 or the Medical Marking Standard No. 1 for medical items, and all packaging must include required bar-coded information. Inspection and acceptance occur at the destination per FAR 52.246-2, with compliance to the DLA Master List of Technical and Quality Requirements mandated. The contract incorporates numerous mandatory Federal Acquisition Regulation (FAR) and Defense Federal Acquisition Regulation Supplement (DFARS) clauses governing compliance in areas such as employment eligibility verification, combating human trafficking, sustainable products, cybersecurity safeguards including NIST SP 800-171 and safeguarding covered defense information, subcontracting for commercial products, and transportation by sea under DFARS 252.247-7023. Contractors must also comply with hazardous materials handling regulations including OSHA’s Hazard Communication Standard and submit hazard labels prior to award. Representation of entity status via Unique Entity ID and CAGE code is required, along with disclosures for covered defense telecommunications equipment under 252.204-7018. Small business participation and joint venture representations must be affirmed with full partner disclosures. Invoicing must be submitted electronically via WAWF using approved document types, and payment processing will rely on DoDAAC data from the award. No evaluation factors, weights, or basis of award have been disclosed

Defense Logistics Agency

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Roche Flu Surveillance Testing ReagentThe contract anticipates the procurement of testing reagents for influenza surveillance under the Forensic Sciences Division of the District of Columbia for fiscal year 2026. The initiative is part of a broader public health effort to monitor flu activity, with reagents intended for use in diagnostic and surveillance testing. While specific quantities, delivery timelines, or technical specifications are not detailed in the forecast, the reagents will support laboratory-based detection and analysis of influenza strains across the jurisdiction. This procurement is categorized as a forecast, indicating it is a planning tool for vendors to prepare for an upcoming solicitation, and no formal solicitation number has been issued as of the posting date. The agency responsible, DFS, is based in Washington D.C., and performance is expected to occur within the district, though no specific location is provided. Vendors interested in participating should monitor future official solicitations, as this forecast serves only as an early indicator of intent and does not constitute a binding request for proposals.

Forensic Sciences (DFS)

POSTED

DEADLINE